Drug application
TAFAMIDIS (TAFAMIDIS)
Drugs@FDA ANDA 218365 · DEXCEL PHARMA
Key facts
| Drug name | TAFAMIDIS |
|---|---|
| Active ingredients | TAFAMIDIS |
| Application type | ANDA |
| Application number | 218365 |
| Company | DEXCEL PHARMA |
| Dosage forms | CAPSULE, ORAL |
| Strength | 61MG |
| Marketing status | None (Tentative Approval) |
| Reference listed drug | No |
| Latest submission status date | Oct 15, 2024 |
At a glance
- 1–9 Submissions
- None Label versions
- None Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.